Concurrent metastatic thymic carcinoma and postirradiation sarcoma.

Area of Science:

• Oncology
• Thoracic Surgery
• Radiation Oncology

Background:

• Thymic carcinoma is a rare malignancy.
• Postirradiation sarcoma is a rare but serious complication of radiation therapy.
• Concurrent malignancies in the same organ are uncommon.

Observation:

• A patient with a history of thymic carcinoma treated with surgery and chemoradiotherapy presented with concurrent lung masses.
• One mass exhibited histology consistent with metastatic thymic carcinoma.
• The second mass was a pleomorphic sarcoma, indicative of postirradiation sarcoma.

Findings:

• This is the first reported case of concurrent metastatic thymic carcinoma and postirradiation sarcoma in the same lung lobe.
• The patient had undergone partial resection and chemoradiotherapy for thymic carcinoma 11 years prior.
• The findings suggest a potential link between radiotherapy for thymic carcinoma and the development of secondary sarcomas.

Implications:

• This case underscores the importance of considering postirradiation sarcoma in patients with a history of thymic carcinoma and radiotherapy who develop recurrent lung masses.
• It may serve as a model for diagnosing and managing similar rare concurrent malignancies.
• Further research into the mechanisms and risk factors for radiation-induced sarcomas in thymic carcinoma survivors is warranted.